C3a and suPAR drive versican V1 expression in tubular cells of focal segmental glomerulosclerosis

Runhong Han(Nanjing General Hospital of Nanjing Military Command), Hao Bao, Xia Wang(University of Leicester), Xiaodong Xu(Hangzhou Normal University), Jin‐Song Shi(Jiangnan University), Weisong Qin(Nanjing General Hospital of Nanjing Military Command), Qin Hou(Nanjing General Hospital of Nanjing Military Command), Shuai Hu(Nanjing General Hospital of Nanjing Military Command), Zhihong Liu(Chinese Academy of Sciences), Zeng Caihong(Nanjing General Hospital of Nanjing Military Command), Minchao Zhang(Harbin Institute of Technology)
JCI Insight
July 10, 2019
10.1172/jci.insight.130986
Cited by 25

Related Papers

Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke
|New England Journal of Medicine|2016|437
The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial
|The Lancet|2023|385
The MEST score provides earlier risk prediction in lgA nephropathy
|Kidney International|2015|297
Glomerular endothelial cell injury and cross talk in diabetic kidney disease
|American Journal of Physiology-Renal Physiology|2014|274
Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial
|The Lancet|2019|271